Useless Treatments Common in Young, Terminal Cancer Patients
3 in 4 get aggressive therapies with painful side effects in last months of their lives, study findsContinue Reading
3 in 4 get aggressive therapies with painful side effects in last months of their lives, study findsContinue Reading
Many smokers can’t shake the haunting FDA-proposed visuals, study findsContinue Reading
Response rate doubled for patients with this blood cancer, study findsContinue Reading
However, actual ability to pay for the drugs is better than in some other countries, researchers addContinue Reading
About a quarter of older patients deemed too frail for chemo responded to Tecentriq, study foundContinue Reading
Patients with advanced disease lived longer when they received this targeted treatment, research showsContinue Reading
Large study found it predicted when cancer DNA was mutating, could help tailor treatments to avoid drug resistanceContinue Reading
Experimental approach doubles time to disease progression, experts findContinue Reading
It has similar effectiveness, safety compared to Herceptin for HER2-positive diseaseContinue Reading
But better tools needed to support their long-term recovery, experts sayContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.